Mutational analysis of FGFR3 in thanatophoric dysplasia, type I.

被引：0
|
作者：
Bellus, GA
Baker, A
Spector, EB
Hunter, AGW
Hecht, J
Lewanda, AF
Szabo, J
Francomano, CA
机构：
[1] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[2] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada
[3] Univ Texas, Houston, TX USA
[4] Ctr Med Genet, Rockville, MD USA
[5] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 1997年 / 61卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
1908
引用
收藏
页码：A326 / A326
页数：1
相关论文
共 50 条
  • [21] Thanatophoric dysplasia, type I
    Herman, T. E.
    Siegel, M. J.
    JOURNAL OF PERINATOLOGY, 2012, 32 (06) : 476 - 478
  • [22] Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)
    Rousseau, F
    ElGhouzzi, V
    Delezoide, AL
    LegeaiMallet, L
    LeMerrer, M
    Munnich, A
    Bonaventure, J
    HUMAN MOLECULAR GENETICS, 1996, 5 (04) : 509 - 512
  • [23] Improved diagnosis of a common mutation (R248C) in the human growth factor receptor 3 (FGFR3) gene that causes type I Thanatophoric dysplasia
    Simsek, M
    Al-Gazali, L
    Al-Mjeni, R
    Bayoumi, R
    CLINICAL BIOCHEMISTRY, 2003, 36 (02) : 151 - 153
  • [24] Dicarboxylic aciduria and 3-hydroxycarboxylic aciduria in a patient of thanatophoric dysplasia type I.
    Okajima, K
    Asai, K
    Niwa, T
    Ohki, S
    Tyson, J
    Malcolm, S
    Sobajima, H
    Wada, Y
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 283 - 283
  • [25] The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor (vol 274, pg 3078, 2007)
    Bonaventure, J.
    Gibbs, L.
    Horne, W. C.
    Baron, R.
    FEBS JOURNAL, 2007, 274 (15) : 4008 - 4008
  • [26] Genotyping of the C742T mutation of the FGFR3 gene causing type 1 thanatophoric dysplasia by high-resolution melting analysis
    Liu, Ying-Na
    Li, Ru
    Li, Dong-Zhi
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2011, 24 (01): : 186 - 188
  • [27] A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia
    Jin, Min
    Yu, Ying
    Qi, Huabing
    Xie, Yangli
    Su, Nan
    Wang, Xiaofeng
    Tan, Qiaoyan
    Luo, Fengtao
    Zhu, Ying
    Wang, Quan
    Du, Xiaolan
    Xian, Cory J.
    Liu, Peng
    Huang, Haiyang
    Shen, Yue
    Deng, Chu-Xia
    Chen, Di
    Chen, Lin
    HUMAN MOLECULAR GENETICS, 2012, 21 (26) : 5443 - 5455
  • [28] Thanatophoric dysplasia type I with syndactyly
    Brodie, SG
    Kitoh, H
    Lipson, M
    Sifry-Platt, M
    Wilcox, WR
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 80 (03): : 260 - 262
  • [29] Mutations in the fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia, hypochondroplasia, and thanatophoric dysplasia: Taiwanese data
    Tsai, FJ
    Tsai, CH
    Chang, JG
    Wu, JY
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 86 (03): : 300 - 301
  • [30] Hypochondroplasia, achondroplasia, and thanatophoric dysplasia caused by mutations of the fibroblast-growth-factor-receptor-3-gene (FGFR3)
    Hilbert, M
    Hilbert, K
    Spranger, J
    Wildhardt, G
    Winterpacht, A
    Wuchner, C
    Zabel, B
    MONATSSCHRIFT KINDERHEILKUNDE, 1998, 146 (07) : 687 - 691
12345